TEAM PLC completes EPIC Book acquisition, adding eight institutional mandates via share issue, a strategic fit but with key financial details still undisclosed.
This article covers information on Team PLC.
LON:TEAMTEAM plc has now completed its previously announced acquisition of the EPIC Book from EPIC Markets (UK) LLP. In plain English, TEAM has bought a package of eight institutional quality investment mandates, which are agreements to manage money on behalf of clients such as institutions under set investment rules.
That matters because this is not a vague strategic statement or a memorandum of understanding. It is a completed transaction. The assets are now effectively in TEAM’s camp, with the deal being paid for through the issue of new shares rather than cash.
The market was first told about this proposed acquisition on 30 March 2026. This latest RNS confirms the final step has happened and sets out the share issue needed to pay for it.
| Item | Detail |
|---|---|
| Assets acquired | Eight institutional quality investment mandates |
| Seller | EPIC Markets (UK) LLP |
| Consideration | 6,301,237 new TEAM ordinary shares |
| Cash consideration | Not disclosed |
| Admission date expected | On or around 3 July 2026 |
| Issued share capital after Admission | 121,237,082 ordinary shares |
| Treasury shares | None |
Admission is the point at which the new shares are formally allowed to trade on AIM, London’s junior stock market for growing companies. TEAM says those 6,301,237 new shares should start trading on or around 3 July 2026.
On the positive side, this looks strategically sensible. TEAM describes itself as an international wealth, asset management and financial services group, so adding eight institutional mandates fits neatly with what it already does.
Institutional mandates can be attractive because they often bring recurring fee income, deeper client relationships and a stronger reputation in the market. If TEAM can retain those mandates and run them well, this could strengthen the quality of its revenue base over time.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
0 viewsLikes
No ratings yet
Enjoying this?
Occasional emails on automation, AI and finance. Unsubscribe any time.
There is also a signalling benefit here. “Institutional quality” is carefully chosen language. It suggests these are not random small accounts, but mandates of a standard that TEAM believes improves the calibre of its business mix.
That said, the RNS stops short of giving the numbers investors really want. There is no disclosure of assets under management tied to these mandates, no revenue contribution, no profit impact and no guidance on how earnings might change. So while the strategic logic looks good, the financial size of the prize is still not disclosed.
The acquisition is being paid for entirely in shares. TEAM is issuing 6,301,237 new ordinary shares to satisfy the total consideration.
For existing shareholders, that has two sides to it. The good news is TEAM has not said it is using cash, which can help preserve balance sheet flexibility. The less good news is dilution, meaning current shareholders own a slightly smaller percentage of the enlarged company once the new shares are issued.
Using the figures in the RNS, TEAM will have 121,237,082 shares in issue after Admission. That means the new shares represent about 5.2% of the enlarged share capital.
That is not tiny, but it is not enormous either. For a deal that potentially adds useful institutional business, a dilution level around that mark may look acceptable to many investors, provided the acquired mandates perform well and stay with the business.
The RNS says the new shares will rank pari passu with the existing ordinary shares. That simply means the new shares will carry the same rights as the old ones, including voting and dividend rights, with no special restrictions or advantages attached.
It also says the shares will be issued free of all liens, charges and encumbrances. Again, in everyday language, that means they are being issued cleanly, without legal claims or security interests hanging over them.
This is where retail investors need to keep a cool head. The announcement tells us the transaction has completed, but it does not tell us how financially meaningful it is.
That lack of detail does not make the deal bad. It just means investors cannot yet judge whether TEAM has bought a modest bolt-on or something more material. When an RNS is this light on financial disclosure, the story is more about direction than immediate valuation impact.
After Admission, TEAM’s total issued share capital will be 121,237,082 ordinary shares, with none held in treasury. Treasury shares are shares a company has bought back but still holds, rather than cancelling them.
The company also highlights that 121,237,082 is the figure shareholders should use as the denominator for disclosure calculations under the FCA’s Disclosure Guidance and Transparency Rules. That sounds technical, but the practical point is simple: if an investor’s holding crosses certain percentage thresholds, this is the share count they should use to work out whether they need to notify the market.
My view is that this is mildly to moderately positive news. Completion removes uncertainty, the acquired mandates appear to fit TEAM’s core business, and the use of shares rather than cash may help preserve financial flexibility.
But it is not a slam-dunk upgrade story on this RNS alone. The market still does not know what these eight mandates are worth in asset terms, what they earn, or how much they could contribute to TEAM’s profits. Without that, it is hard to put a firm number on the upside.
So the right takeaway is probably this: strategically encouraging, financially unproven. Investors who already like TEAM’s broader growth story may see this as another sensible building block. More cautious investors will want follow-up evidence that the EPIC Book adds meaningful recurring income and improves scale.
TEAM has completed the acquisition of eight institutional investment mandates and paid for them with 6,301,237 new shares. The enlarged share capital will be 121,237,082 shares once Admission takes place on or around 3 July 2026.
The deal looks like a clean strategic fit and could strengthen TEAM’s institutional credentials. The catch is that the company has not disclosed the most important financial details, so for now this is a positive operational step rather than a fully quantifiable earnings story.
That is often how small-cap investing works. First you get the strategic move. Then, if management executes properly, the numbers follow.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.